http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104478973-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
filingDate 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104478973-B
titleOfInvention It is a kind of to recrystallize the method for reducing spiramvcin impurity
abstract A kind of to recrystallize the method for reducing the mould impurity of spiral, step is:(1) it is potassium dihydrogen phosphate is soluble in water, it is then 2~3 with careless acid for adjusting pH value;(2) by the mixed solution obtained by solid-state spiramvcin input step (1), keeping temperature is 25~40 DEG C of stirring and dissolvings;(3) it is 12~15% sodium hydroxide solutions to mass concentration is added in step (2) gained spiramvcin solution, heat up 60~90min, and then keeping temperature is stirred crystallization at 50~65 DEG C;(4) wet-milling is centrifugally separating to obtain, wet-milling repeat step (1), (2), (3) operate, wet-milling drying is obtained again can obtain low impurity spiramvcin.This method is the dosage by changing potassium dihydrogen phosphate and oxalic acid, during spiramvcin finished product is then re-dissolved into potassium dihydrogen phosphate and oxalic acid solution, is recrystallized, and the relevant material in spiramvcin is further removed, and then improve product quality.
priorityDate 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426283535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451911571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451080591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153274329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414059530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9275
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407169869

Total number of triples: 36.